These collective studies indicate that microglial activation is a primary cause of CSF1R-associated leukoencephalopathy and inhibiting microglial activation by minocycline may be an effective strategy to improve behavioral performance, based on our findings in our mouse model of ALSP. Here, CSF1R is linked to Leukoencephalopathy.